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Lipid raftslasma membrane of target cells has been shown to be important for the infection
by SARS-CoV. We show that cholesterol depletion by treatment with methyl-β-cyclodextrin (mβCD) affects
infection by SARS-CoV to the same extent as infection by vesicular stomatitis virus-based pseudotypes
containing the surface glycoprotein S of SARS-CoV (VSV-ΔG-S). Therefore, the role of cholesterol for SARS-
CoV infection can be assigned to the S protein and is unaffected by other coronavirus proteins. There have
been contradictory reports whether or not angiotensin-converting enzyme 2 (ACE2), the cellular receptor for
SARS-CoV, is present in detergent-resistant membrane domains. We found that ACE2 of both Vero E6 and
Caco-2 cells co-puriﬁes with marker proteins of detergent-resistant membranes supporting the notion that
cholesterol-rich microdomains provide a platform facilitating the efﬁcient interaction of the S protein with
the cellular receptor ACE2. To understand the involvement of cholesterol in the initial steps of the viral life
cycle, we applied a cell-based binding assay with cells expressing the S protein and cells containing
angiotensin-converting enzyme 2 (ACE2). Alternatively, we used a soluble S protein as interaction partner.
Depletion of cholesterol from the ACE2-expressing cells reduced the binding of S-expressing cells by 50%
whereas the binding of soluble S protein was not affected. This result suggests that optimal infection requires
a multivalent interaction between viral attachment protein and cellular receptors.
© 2008 Elsevier Inc. All rights reserved.Introduction
Cellular infection by enveloped viruses proceeds via (i) the
interaction of viral surface proteins with cell surface receptors to
achieve the attachment of virus particles to the cell surface and (ii) the
initiation of a fusion event that is usually triggered by a conforma-
tional change of a fusion protein (reviewed by Marsh and Helenius,
2006). Other features of this process vary between different groups of
viruses. The viral membrane may fuse with either the plasma
membrane or, upon endocytotic uptake of the virion, with the
endosomal membrane. For many viruses the fusion protein has to be
cleaved into subunits whichmay occur during transport to the plasma
membrane or after virus release from the cell (Garten and Klenk,lende).
tsklinikum Bonn, Medizinische
l rights reserved.1999). Another variant is the involvement of membrane microdo-
mains in the fusion process (Chazal and Gerlier, 2003).
Within a membrane, sphingolipids and cholesterol form micro-
domains with an increased structural order (reviewed by Simons and
Ikonen, 1997). Cholesterol maintains the tight packaging of the
sphingolipids with their saturated fatty acid chains. Some proteins
partition into these microdomains while others are excluded from
them. The tight packaging of the lipid components renders the
proteins resistant to solubilization by non-ionic detergents at 4 °C.
Depletion of cholesterol from the membrane by drugs – e.g. by
methyl-β-cyclodextrin (mβCD) – abolishes the detergent resistance.
Pretreatment of cells with mβCD has revealed that viruses differ in
their dependence on cholesterol for initiation of infection. For several
viruses, e.g. Human immunodeﬁciency virus,Murine leukemia virus and
Herpes simplex virus, it has been shown that they are sensitive to a
reduction of the cholesterol content in the plasma membrane (Liao
et al., 2001; Lu et al., 2002; Bender et al., 2003). For some viruses –
inﬂuenza viruses and Canine distemper virus – cholesterol-enriched
microdomains appear to be important in the viral membrane, but not
Fig.1. Effect of cholesterol depletion and replenishment on virus infection. (A) Vero CCL-
81 cells were treated with different mβCD concentrations. After removal of mβCD by
three washing steps, cells were infected by VSV-ΔG-S (white bars) and the control
viruses VSVΔG-G (black bars) and IBV (hatched bars). At 8 h p.i. cells were ﬁxed.
Infection was determined by counting eGFP-expressing (VSV-ΔG viruses) or by
immunostaining (IBV). (B) Untreated and mβCD-treated Vero cells were incubated in
the absence (−) or presence (+) of water-soluble cholesterol diluted in medium followed
by infection with VSV-ΔG pseudotype viruses. Infectivity rates were determined as
described for 1A. Each bar represents the mean±standard deviation of 3 independent
experiments.
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et al., 2007). On the other hand, Vesicular stomatitis virus does not
show a decreased infectivity after depletion of cholesterol from either
the viral or cellular membrane (Popik et al., 2002; Imhoff et al., 2007).
Coronaviruses are enveloped viruses with a positive-stranded RNA
genome (reviewed by Enjuanes et al., 2006). Three viral proteins are
incorporated into the viral membrane, the M, E and S proteins. The
latter plays an important role in the initiation of infection. For several
coronaviruses, Murine hepatitis virus, Infectious bronchitis virus,
human coronavirus 229E and SARS-CoV, it has been shown that
cholesterol depletion from the plasma membrane of the target cells
reduces the efﬁciency of infection (Nomura et al., 2004; Thorp and
Gallagher, 2004; Choi et al., 2005; Imhoff et al., 2007; Li et al., 2007).
For SARS-CoV, the cholesterol dependence has been shown either
with infectious virus or with viral pseudotypes. However, the
explanation of the results is difﬁcult because there are two reports
that the cellular receptor for SARS-CoV, angiotensin-converting
enzyme 2 (ACE2) is not present in detergent-resistant membrane
domains but rather in the detergent-soluble fraction. Warner et al.
(2005) obtained this result for CHO cells transiently expressing ACE2
and Li et al. (2007) for endogenous ACE2 of Vero E6 cells. By contrast,
Lu et al. (2008) recently identiﬁed ACE2 as a raft protein similar to
caveolin-1. So far there was no experimental indication whether
cholesterol is required for binding of the virus to the cell surface or for
the subsequent fusion event.
To clarify the points raised above, here we show that the
cholesterol depletion and replenishment affects the infection efﬁ-
ciency of SARS-CoV to the same extent as that of pseudotypes
containing the S protein of SARS-CoV. Furthermore, we show that
ACE2 is present in detergent-resistant membranes of both Vero E6
cells and Caco-2 cells. Finally, we provide evidence that in a cell-based
binding assay, cholesterol depletion affects the interaction of the S
protein with ACE2.
Results
S-protein-mediated entry by SARS-CoV is cholesterol-dependent
For our studies on the importance of cholesterol in the initiation of
an infection by SARS-CoV, we used viral pseudotypes based on
replication-deﬁcient VSV containing the S protein of SARS-CoV (VSV-
ΔG-S). This approach allowed us to determinewhether the cholesterol
dependence of SARS-CoV entry that has been reported recently (Li
et al., 2007) can be assigned solely to the S protein or whether it is
dependent on additional coronavirus proteins. As control viruses we
used pseudotypes containing the G protein (VSV-ΔG-G) of VSV that is
unaffected by cholesterol depletion (Popik et al., 2002; Imhoff et al.,
2007) and Infectious bronchitis virus (IBV), an avian coronavirus that
has recently been shown to be sensitive to reduction of the cholesterol
content in the plasma membrane of the target cell (Imhoff et al.,
2007).
To investigate the involvement of cholesterol and a possible role of
lipid rafts during the initial steps of a SARS-CoV infection, we used
methyl-β-cyclodextrin (mβCD) to deplete cholesterol from target
cells. MβCD is known to capture cholesterol and thereby sequestering
cholesterol from the plasma membrane. As a result, lipid micro-
domains are disrupted and biological processes that depend on them
are blocked. First, we determined the effect of mβCD treatment on the
cholesterol content of Vero CCL-81 cells. These cells were used
because in contrast to Vero E6 cells that are commonly used for
propagation of SARS-CoV, the CCL-81 subline is sensitive to our
control virus IBV. Using a ﬂuorometric method based on an enzyme-
coupled reaction that detects both free cholesterol and cholesteryl
esters we found that incubation with increasing amounts of mβCD
resulted in a decrease of the cholesterol levels in Vero cells. At an
mβCD concentration of 10 mM, the concentration of cholesterol wasreduced by about 50% (data not shown). To exclude that mβCD
treatment has toxic effects we analyzed the viability of the cells after
drug exposure. Up to a concentration of 10 mM mβCD, the cells
exhibited viability rates comparable to that of untreated cells (data not
shown).
To analyze whether cholesterol depletion affects entry mediated
by the SARS-CoV S protein, we pretreated Vero CCL-81 cells with
mβCD for 30 min and – after three washing steps – infected the cells
by either VSV-ΔG-S pseudotypes or the control viruses VSV-ΔG-G and
IBV, respectively. At 8 h p.i., the infectivity was determined by
counting the ﬂuorescent cells. In the case of pseudotype-infected cells,
ﬂuorescence was derived from eGFP expressed from the VSV genome.
IBV-infected cells were visualized by immunostaining. As shown in
Fig. 1A, mβCD treatment inhibited the infection by VSV-ΔG-S in a
dose-dependent fashion. At mβCD concentrations of 2.5 mM and
10mM, the percentage of infected cells was reduced by about 20% and
50%, respectively, compared to the untreated cells. For the infection by
Vesicular stomatitis virus (VSV) or VSV-G-pseudotyped viruses, it has
been reported that virus entry is not affected by depletion of cellular
cholesterol (Popik et al., 2002; Thorp and Gallagher, 2004; Imhoff
et al., 2007). We conﬁrmed these results with our pseudotype system
(Fig. 1A). For Infectious bronchitis virus (IBV), an avian coronavirus, it
has been demonstrated that the infection is dependent on cellular
cholesterol (Imhoff et al., 2007). Consistent with these data, IBV
infection of cholesterol-depleted cells resulted in a decreased number
of infected cells (Fig. 1A). At an mβCD concentration of 10 mM, the
infection was reduced by about 40%. To assess whether the effect of
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cholesterol-depleted cellular membranes and analyzed the recovery
of virus infection. As shown in Fig. 1B, the addition of cholesterol
reversed the inhibitory effect of mβCD on VSV-ΔG-S infection. In fact,
infection rates even exceeded the values determined for cells that had
not been treated with mβCD. The infectivity of VSV-ΔG-G was not
affected by cholesterol supplementation.
To ﬁnd out how the cholesterol dependence of the pseudotype
infection relates to infection by SARS-CoV, Vero E6 cells were treated
with 10 mM mβCD for 30 min at 37 °C followed by the infection with
SARS-CoV at a multiplicity of infection (MOI) of about 0.0005. After
the adsorption period, cells were overlaid by methylcellulose and
incubated for 96 h for plaque formation to occur. As shown in Fig. 2,
compared to untreated control cells the infectivity in cholesterol-
depleted cells was reduced by about 60% at 10 mM mβCD treatment.
This result is comparable to that obtained with pseudotype virus
containing the S protein of SARS-CoV (Fig. 1A). We also included a
control in which exogenous cholesterol (100 μg/ml) was added to
mβCD-treated Vero cells for 30 min prior to infection with SARS-CoV.
Under these conditions of cholesterol replenishment the inhibitory
effect was abolished (Fig. 2). Our data conﬁrm that cholesterol plays a
critical role in SARS-CoV entry and demonstrate that the cholesterol
dependence is a feature of the S protein and independent of other
coronavirus proteins.
Role of cholesterol in binding of spike protein to ACE2
We analyzed the amount of ACE2 expressed on the cell surface
after mβCD treatment andwe found that cholesterol depletion did not
affect the surface expression level of the SARS-CoV receptor (data not
shown). This is in contrast to a recent report that cholesterol depletion
results in a decreased expression level of ACE2 (Li et al., 2007).
Possible reasons for this discrepancy will be discussed in a later
section. To understand by what mechanism cholesterol depletion
inhibits virus entry and to deﬁne the molecular step at which the
inhibition occurs we established a cell-based binding assay as well as a
binding assay with a soluble spike protein fused to human Fc. For the
cell-based binding assay we generated a cell line derived from baby
hamster kidney cells (BHK21) that constitutively expresses the SARS-
CoV spike glycoprotein (BHK-SΔ18). To monitor the amount of cells
that bind to ACE2-expressing Vero E6 cells, we applied the ﬂuorescent
fatty acid dye BODIPY FL C12 that incorporates into the plasma
membrane. Fluorescent dye-labeled BHK-SΔ18 cells were resus-
pended in serum-free culture medium and added to a Vero E6Fig. 2. Effect of cholesterol depletion/replenishment on SARS-CoV replication.
Untreated, mβCD-treated and cholesterol replenished Vero cells were infected by
SARS-CoV and overlaid with methylcellulose. At 96 h p.i., the cells were stained and the
plaques were counted. The bars represent the mean values±standard deviation of 3
independent experiments.
Fig. 3. Cell-based binding assay for the interaction of S protein with ACE2. BHK-SΔ18
cells were grown to monolayers in the presence of the ﬂuorescent fatty acid BODIPY FL
C12. After detachment by treatment with Accutase, cells were used for overlay assays.
(A) Conﬂuent Vero E6 cells were overlaid with PBS (a and b), BHK-SΔ18 (c and d), BHK-
SΔ18 that had been pretreated with anti-SARS serum (e and f), or with ﬂuorescence-
labeled BHK21 cells (g and h). Phase-contrast pictures are shown in panels on the left
side (a, c, e, g); pictures obtained by ﬂuorescence microscopy are shown on the right (b,
d, f, h). (B) Conﬂuent Vero E6 cells were treated with different concentrations of mβCD.
In cholesterol replenishment experiments, cells were incubated in the presence of
cholesterol. After these treatments, ﬂuorescence-labeled BHK-SΔ18 cells were added.
Bound cells were detached by trypsin treatment and subjected to ﬂow cytometry. The
ﬁgures show a representative image. The bars represent the mean±standard deviation
of 4 independent experiments.monolayer in a ratio of 1/2 (BHK-SΔ18 cells/Vero E6 cells). Unbound
cells were removed by washing with PBS containing 0.5 M sodium
chloride. As shown in Fig. 3A (panels c and d), BHK cells expressing the
S protein of SARS-CoV bound efﬁciently to Vero E6 cells, whereas only
a few cells of the parental BHK cells were detected (panels g and h).
Fig. 5. Isolation of detergent-resistant membranes by step gradient centrifugation.
Conﬂuent Vero E6 cells were lysed in 1.0% Triton X-100 three to four days after initial
seeding and cell lysates were subjected to step gradient ultracentrifugation. Fractions
(1 ml) were collected from top to the bottom subjected to SDS-PAGE and analyzed by
immunoblotting with antibodies directed against ACE2, Flotillin-2 and LAMP-2. The
fractionation was performed with untreated cells (A) or cells that had been pretreated
with mβCD (B). Blots show a representative experiment out of three.
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SARS-CoV reduced the binding to a level comparable to that of BHK
cells, i.e. about 3% (compare panels e and f with panels g and h). To
address the question whether in our assay S protein interacts with
ACE2 or another cellular protein, we performed the binding assay with
three Vero cell lines that differed in the expression of ACE2. As
determined by FACS analysis, the expression level of ACE2 on the
surface of the Vero cell lines E6, CCL-81, and RIE15 was characterized
by the ratio 30:23:5 (Fig. 6A, supplemental material). Compared to
Vero E6 (100%) the number of bound BHK-SΔ18 cells was reduced to
about 85% and 22%, when the CCL-81 or RIE15 sublines of Vero cells
were used for the binding assay (Fig. 6B, supplemental material).
These results indicate that the binding of BHK-SΔ18 cells to Vero E6
cells is mediated by the S protein of SARS-CoV.
For quantitative evaluation of the binding, cells were detached by
trypsin digestion, resuspended in PBS containing 0.5% bovine serum
albumin (BSA) and subjected to ﬂow cytometry. Using this assay, we
analyzed the importance of cholesterol for the binding. Conﬂuent Vero
E6 cells were treated with mβCD followed by the addition of BODIPY
FL C12-labeled BHK-SΔ18 cells. The treatment of Vero E6 cells with
mβCD inhibited the binding of BHK-SΔ18 cells to Vero E6 cells in a
dose-dependent manner (Fig. 3B). At an mβCD concentration of
10 mM, binding was decreased to about 50% which is similar to the
reduction of the infection rate observed with VSV-ΔG-S (Fig. 2A) and
SARS-CoV (Fig. 3) at the same mβCD concentration. The detrimental
effect of the cholesterol depletion on the binding capacity of BHK-
SΔ18 cells was abolished by the addition of exogenous cholesterol
(Fig. 3B). The treatment with cholesterol even resulted in a 2-fold
increase in binding of S-expressing cells to receptor-expressing cells.
MβCD or cholesterol treatment of parental BHK cells did not affect the
unspeciﬁc binding to Vero E6 cells (data not shown). The cell-based
binding data suggest that cholesterol is important for optimal
interaction of the spike protein with the receptor ACE2. This assay
allows multi-ligand interactions which may be facilitated by cellular
receptors arranged in membrane microdomains. To determine
whether the interaction of isolated S proteins with membrane-
bound ACE2 is also cholesterol-dependent, we applied a binding assay
with soluble S protein. Cholesterol-depleted or replenished Vero E6
cells were incubated with soluble S proteins followed by the
quantiﬁcation of bound protein (Fig. 4). Compared to the cell-basedFig. 4. Effect of cholesterol deletion on the binding of soluble spike glycoprotein to Vero
E6 cells. For the binding assay with soluble SARS-CoV spike protein cholesterol-
depleted or repleted Vero E6 cells were incubated with soluble S protein and bound S
proteins were subsequently detected by using an anti-human FITC-conjugated
secondary antibody followed by ﬂow cytometry. The bars represent the mean
±standard deviation of 3 independent experiments.binding assay, binding of the soluble spike protein construct was not
dependent on cholesterol; similar amounts of S protein were bound
whether or not the cells were pretreated with mβCD and/or
cholesterol comparable to control cells. To avoid the criticism that
the soluble S protein is not functional or not properly folded we
performed experiments showing that the S1-Fc construct used is
recognized by an antibody directed against the S protein of SARS-CoV
(Fig. 7A, supplemental material). Furthermore, we demonstrated that
the soluble S protein binds to transfected BHK cells expressing ACE2
but not to non-transfected cells. Binding was prevented by an
antibody directed against S protein (Fig. 7B, supplemental material).
ACE2 is localized in cholesterol-rich microdomains
As SARS-CoV entry is cholesterol-dependent and cholesterol is
enriched in detergent-resistant membrane microdomains, one might
expect that the cellular receptor for SARS-CoV, ACE2, is present in
detergent-resistant membranes. However, it has been reported that,
ACE2 is not located in detergent-resistant membranes (Warner et al.,
2005; Li et al., 2007). On the other hand, Lu et al. (2008) recently
detected ACE2 in the raft fraction of Vero E6. To clarify this
discrepancy, we also analyzed whether ACE2 is resistant to solubiliza-
tion by Triton X-100 at 4 °C. In contrast to previous reports (Warner
et al., 2005; Li et al., 2007) we found that a substantial amount of ACE2
from Vero E6 cells was ﬂoating to the light fractions of the gradient
where the detergent-resistant membranes are expected as indicated
by the raft marker ﬂotillin-2 (Fig. 5A). By contrast, the non-raft marker
LAMP-2 was completely solubilized and recovered from the bottom
fraction of the gradient. When mβCD-treated Vero E6 cells were
subjected to such an analysis, ACE2 was detected only in the
detergent-soluble fraction (Fig. 5B). This result indicates that a
substantial portion of the SARS-CoV receptor ACE2 is associated
with cholesterol-rich membrane microdomains that are resistant to
detergent-solubilization at 4 °C. The same result was obtained when
Caco-2 cells were analyzed (data not shown). The discrepancy
between these results and previous reports will be discussed below.
Discussion
Our work extended the current knowledge about the cholesterol
dependence of the SARS-CoV entry in the following way: (i) by
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S protein of SARS-CoV we show that the cholesterol dependence is a
property of the S protein and independent of other viral proteins, (ii)
in contrast to two previous reports (Warner et al., 2005; Li et al., 2007)
and in agreement with a recent report (Lu et al., 2008) we show for
two cell lines that are sensitive to SARS-CoV that ACE2 is present in
detergent-resistant membranes; (iii) for the ﬁrst time we present
experimental evidence indicating that cholesterol is required for
efﬁcient S-mediated binding to ACE2-containing cells.
The importance of cholesterol in the plasma membrane of the
target cell has been shown for a number of viruses (Liao et al., 2001;
Lu et al., 2002; Bender et al., 2003) including some coronaviruses
(Nomura et al., 2004; Thorp and Gallagher, 2004; Choi et al., 2005;
Imhoff et al., 2007; Li et al., 2007; Lu et al., 2008). Our results not
just conﬁrm this ﬁnding for SARS-CoV but go beyond this initial
observation and provide additional data that contribute to a better
understanding of the importance of cholesterol for infection by
SARS-CoV.
We have demonstrated that cholesterol depletion affects not only
infection by SARS-CoV but also S-mediated infection of VSV
pseudotypes. In fact, the inhibitory effects observed in both systems
are comparable. VSV itself is not impaired in its ability to infect cells
that have a reduced content of cholesterol (Thorp and Gallagher, 2004;
Imhoff et al., 2007). Based on these ﬁndings, the cholesterol
dependence of SARS-CoV can be attributed to the S protein and
appears to be unaffected by other viral proteins. Furthermore, our
approach shows that cholesterol depletion reduces infectivity in a
single replication cycle by about 50%.
The functions of the S protein in the early phase of infection are (i)
binding to the cell surface receptor, and (ii) induction of the fusion
between the viral and the cellular membrane. Our data obtained with
the cell-based binding assay indicate that S-mediated binding to
target cells is reduced by depletion of cholesterol from the ACE2-
containing cells. On the other hand, the binding of soluble S protein
was not affected. The differences can be explained by a multivalent
interaction between the viral glycoproteins and cellular receptor
molecules in the case of the cell-based binding assay which may be
facilitated by the concentration of receptors in membrane micro-
domains. In contrast, soluble S proteins can only interact with
individual ACE2 molecules and therefore, the binding efﬁciency is
similar whether or not the receptor molecules are arranged in
microdomains. Virus binding to cells does also allow multivalent
interactions between the viral attachment protein and the cellular
receptors. Therefore, arrangement of ACE2 in membrane microdo-
mains would explain why cholesterol depletion from target cells
reduces the infectivity of SARS-CoV by about 50%.
Our analysis of the surface expression indicates that cholesterol
depletion does not reduce the amount of ACE2 protein on the surface
of Vero cells. This ﬁnding argues against an explanation that
quantitative differences in the availability of the cellular receptor
account for the reduced binding efﬁciency. It has been reported that
the amount of ACE2 expressed on the cell surface is reduced to some
extent by cholesterol depletion (Li et al., 2007). The difference to our
data may be due to different staining protocols. In our analysis, the
anti-ACE2 antibodies were added prior tomβCD treatment whereas in
the report by Li and co-workers, the antibodies were added after
cholesterol depletion. We interpret these results such that cholesterol
in the plasma membrane affects the conformation of ACE2 and thus
the presentation of the antigenic epitopes. It should be noted that in a
recent report the amount of ACE2 on the surface of Vero E6 cells was
also not found to be reduced (Lu et al., 2008) which is in agreement
with our data.
A straightforward explanation of the effect of cholesterol depletion
on the binding of S proteinwould be that ACE2 is located in DRMs and
that the concentration of this receptor in microdomains increases the
efﬁciency of binding. The depletion of cholesterol from ACE2-expressing target cells might result in the dispersion of ACE2
molecules on the cell surface and abolish the spatial concentration
of ACE2 in membrane microdomains. In fact, we found that a
substantial amount of ACE2 from Vero E6 cells was colocalizing with
ﬂotillin-2, a marker for detergent-resistant membranes, and choles-
terol depletion resulted in a reduction of ACE2 in the detergent-
resistant membrane fraction after Triton X-100 solubilization. The
same result was obtained when ACE2 from Caco-2 cells was analyzed
(data not shown). The ﬁnding that ACE2 is located in DRMs is
contradictory to previous reports that ACE2 is mainly detected in
detergent-sensitive fractions (Warner et al., 2005; Li et al., 2007) but
in agreement with Lu et al. (2008). The reason for this discrepancy
with the former two reports may be the different experimental
conditions. In one report, nonpolarized Chinese hamster ovary cells
were analyzed (Warner et al., 2005), whereas the polarized cell lines
Vero E6 and Caco-2 cells were used in our study. Furthermore, we
determined the membrane association of endogenous ACE2, whereas
others analyzed hamster cells overexpressing human ACE2 protein
(Warner et al., 2005). In one report, the ACE2 distribution was also
analyzed in Vero E6 cells (Li et al., 2007); however, it is not indicated at
what time point after seeding the detergent treatment was carried
out. In our experiments conﬂuent Vero E6 cells were used three to four
days after initial seeding; the differentiation state of the cells may
inﬂuence the ACE2 distribution in the membrane environment. We
found that endogenous ACE2 is located in detergent-resistant
membranes of cells that are sensitive to infection by SARS-CoV. This
location provides an explanation of the cholesterol dependence of the
virus infection, most-likely during the binding of the virus to its
receptor. A similar observation was reported for the binding of HIV-1
to dendritic cells (DC). Treatment of DCs with mβCD abolished virus
binding at 4 °C indicating that DC-speciﬁc HIV-receptors are present in
the cholesterol-enriched microdomains of the lipid bilayer (Gummu-
luru et al., 2003). As mentioned above, the importance of cholesterol-
rich microdomains for infection by SARS-CoV may be a concentration
effect on cellular receptor proteins. A clustering of ACE2 in certain
areas of the membrane may allow multivalent binding of virus
particles to the cell surface. In this way, microdomains may increase
the efﬁciency of infection, but are not an absolute requirement for the
entry process. This explanation is in agreement with the ﬁnding that
cholesterol depletion reduces the susceptibility to infection but does
not abolish it. Infectivity rates were reduced by about 50–60%. This
may appear not to be a dramatic effect. However, infection of a host
requires many replication cycles. Therefore, a virus that is able to
produce a twofold higher number of infectious particles in one round
of infection should have a huge advantage to survive in the long run.
This is also evident from the other reports on the cholesterol
dependence of SARS-CoV. These authors did not determine the
infectivity of the mβCD-treated virus but the effect of mβCD
treatment on a multi-cycle replication of SARS-CoV. Using this
approach a 90% reduction of virus in the supernatant was found
demonstrating the importance of efﬁcient infectionmediated by ACE2
in detergent-resistant membranes.
Materials and methods
Cells
All cell lines were propagated as adherent monolayer cultures in
the presence of 5–10% heat-inactivated fetal calf serum (FCS) and a
penicillin/streptomycin antibiotic cocktail. Baby hamster kidney
(BHK21, German Collection of Microorganisms and Cell Cultures,
Braunschweig, Germany) and Vero E6 cells (Collection of Cell Lines in
Veterinary Medicine, Friedrich-Loefﬂer-Institute, Insel Riems, Ger-
many) were grown in Eagle's minimal essential medium (EMEM),
Vero CCL-81, Vero RIE15, and 293T cells were grown in Dulbecco's
minimal essential medium (DMEM). BHK-G43 (Hanika et al., 2005)
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cultured in EMEM supplemented with the antibiotics zeocin (0.5 mg
ml−1) and hygromycin B (0.25 mg ml−1).
Viruses
Replication-incompetent VSV with the G gene replaced by the
eGFP gene (VSV-ΔG) was generated as described previously (Hanika
et al., 2005). This approach was also used for the generation of SARS-
CoV S-pseudotyped VSV (VSV-ΔG-S) as reported previously (Ren et al.,
2006). Stock virus of the IBV strain Beaudette-US, and SARS-CoV strain
Frankfurt were propagated on Vero CCL-81 and Vero E6 cells,
respecitvely. VSV-ΔG-G-, VSV-ΔG-S- and IBV Beaudette-US viruses
were stored at −80 °C and infectivity was determined by TCID50
titration on BHK21, Vero E6 and Vero CCL-81 cells, respectively.
Virus infections
In general, untreated or cyclodextrin/cholesterol-treated cells were
cultured on glass coverslips and washed prior to infection. VSV-ΔG
viruses and IBV strain Beaudette were diluted in medium and ∼102
infectious unitswere applied to the cells and allowed to bind at 37 °C for
1 h. After removal of the inoculum, medium containing 3% FCS was
added to the cells. At 8 h p.i., the infected cells were washed once and
ﬁxed with 3% paraformaldehyde. VSV-ΔG virus infected cells were
determined by counting eGFP-expressing cells. To monitor IBV infec-
tion, the ﬁxed cells were permeabilized with 0.2% Triton X-100 and IBV
antigen was stained by incubation with a rabbit serum raised against
IBV strain Beaudette followed by incubation with FITC-conjugated
secondaryantibody. For infectionwith SARS-CoV (Frankfurt strain) Vero
E6 cells were cultured in 6-well culture plates to reach conﬂuency. The
next day the cells were infectedwith amultiplicity of infection (MOI) of
0.0005. Virus was allowed to attach to the cells for 1 h at 37 °C. After
having washed away unbound virus with PBS, cells were overlaid with
DMEM containing 1%methylcellulose and cells were further incubated
for 96 h. For visualizing plaque formation, cells were ﬁxed with 4%
paraformaldehyde followed by staining with crystal violet.
Baby hamster kidney cell line expressing SARS-CoV spike glycoprotein
A BHK21 cell line was generated that expresses the SARS-CoV S
glycoprotein (BHK-SΔ18). The cell line was designed for the
generation of viral pseudotypes containing the S proteins of SARS-
CoV. Efﬁcient pseudotyping was reported only for S constructs that
lacked the carboxyterminal amino acids (Nie et al., 2004). Therefore,
a mutant was generated with a deletion of the 18 carboxyterminal
amino acids in the cytoplasmic tail of the S protein. For the
generation of BHK-SΔ18 cells, the inducible mammalian GeneSwitch
System (Invitrogen) was used. The following primers: 5′-
TTTTGGATCCATCATGGATGCAATGAAGAGAGGGCTCTG-3′ and 5′-
TTTTGAATTCTCACTTCAGGCAGCTGCAGCAGCTGGTCAT-3′ were
designed to generate the truncated version of the SARS-CoV S
protein by using a synthetic, codon-optimized sequence of the S
gene (amino acid sequence is identical to strain BJ01, GenBank
Accession No. AY278488) as a template. The BamHI/EcoRI digested
and puriﬁed PCR product was inserted into the vector pGeneC to
give pGeneC-SΔ18. The total open reading frame was sequenced and
found to be correct. A cell line expressing the truncated SARS-CoV S
protein was generated as described by the manufacturer. In brief,
pGeneC-SΔ18/pSwitch-cotransfected BHK21 cells were cultured for
14 days in selection medium containing hygromycin B (500 μg ml−1)
and zeocin (1 mg ml−1). Cell clones were isolated by limiting dilution
and analyzed for mifepristone-induced SARS-CoV S expression by
Western blotting and the production of VSV-ΔG-S pseudoparticles as
described above. After a recloning step, one cell clone was selected
and used throughout the study.Cyclodextrin and cholesterol treatments of Vero cells
Methyl-β-cyclodextrin (mβCD, Cat. No. C-4555) and water-soluble
cholesterol (Cat. No. C-4951) were obtained from Sigma-Aldrich. Vero
CCL-81 or Vero E6 cells were treated with different concentrations of
mβCD diluted in EMEM at 37 °C for 30 min. In cholesterol
replenishment experiments, cells were ﬁrst incubated with mβCD.
After threewashing steps cholesterol was diluted in serum-free EMEM
and incubated with the cells at 37 °C for 30 min at a concentration of
100–400 μg ml−1. For cholesterol measurement, the cells werewashed
with PBS, lysed in NP-40 lysis buffer and cholesterol levels were
assayed using the Amplex Red Cholesterol Assay kit (Molecular
Probes) following the manufacturers' protocol. Cell viability was
assayed by using theWST-1 reagent (Roche). In brief, Cell Proliferation
Reagent WST-1 was diluted 1:10 in medium and was then added to
the cells. After incubation for 1 h at 37 °C, the absorbance was
measured in an ELISA reader at 450 nm. In all experiments control
cells were incubated with medium at 37 °C for the indicated time
periods.
Binding assays and ﬂow cytometry
For the cell-based binding assay BHK-SΔ18 cells were grown in
175 cm2 culture ﬂasks to 80% conﬂuency. Culture medium was
replaced with fresh medium containing 0.25 μg ml−1 BODIPY FL C12
(Molecular Probes), 5% FCS and 10−8 M mifepristone to induce S
protein expression. After Accutase treatment (PAA Laboratories), the
cells were resuspended in EMEM, counted and adjusted to
3×105 cells/ml. Vero E6 cells were incubated overnight in 24-well
plates to conﬂuent cell monolayers. Following cholesterol depletion/
repletion Vero E6 cells were overlaid with 500 μl BHK-SΔ18 cell
suspension for 2 h at 4 °C in the dark. After three washing steps with
ice-cold PBS containing 0.5 M sodium chloride, binding of cells was
visualized by ﬂuorescence microscopy. For the quantiﬁcation of Vero
E6, BHK-SΔ18 cell–cell interaction, the cell mixture was detached,
resuspended in PBS containing 1.0% BSA and subjected to ﬂow
cytometry on a Beckman Coulter Epics XL ﬂow cytometer and
analyzed using EXPO32 analysis software. To determine the speciﬁcity
of the cell–cell interaction, BHK-SΔ18 cells were pre-incubated with
anti-SARS rabbit serum diluted 1:50 followed by the cell overlay onto
Vero E6 cells. BODIPY FL C12-labeled BHK21 cells were used to
determine unspeciﬁc binding. For the binding assay with soluble S
protein, soluble Fc fusion proteins were transiently expressed in
BHK21 cells, concentrated from culture supernatant by using
CentriconPlus ultraﬁlters (Millipore), and incubated for 60 min on
ice with cholesterol-depleted/repleted Vero E6 cells. Bound Fc fusion
proteins were subsequently detected by using an anti-human FITC-
conjugated secondary antibody (Dako) followed by ﬂow cytometry.
Preparation of detergent-resistant membranes (DRM)
DRMs were prepared according to a published method (Castel-
letti et al., 2008) with modiﬁcations. All steps were carried out at
4 °C. Vero E6 cells were cultured in 60 mm culture dishes and were
maintained for 3 days after reaching conﬂuency. After washing with
ice-cold PBS cells were scraped into 1 ml PBS containing 1.0% (w/v)
TX-100 and Complete protease inhibitor cocktail (Roche Pharmaceu-
ticals), homogenized by repeated passage through a 21-G needle and
then maintained on ice for 2 h. A post-nuclear supernatant was
prepared (7000 ×g, 15 min), the samples were diluted in iodixanol to
a ﬁnal concentration of 35% and 2 ml aliquots were transferred to
SW-41 tubes. The samples were then overlaid with 30% (w/v, 8 ml)
and 5% (w/v, 2 ml) on top of iodixanol in PBS. After centrifugation at
100,000 ×g for 18 h at 4 °C in a Beckman SW-41 rotor 1 ml fractions
were harvested from the top to the bottom of the tube followed by
separation under reducing conditions and the samples were then
221J. Glende et al. / Virology 381 (2008) 215–221analyzed for the protein content by western blotting. For the
detection of ACE2 a goat anti-ACE2 polyclonal antibody (R&D
System; 1:50) was used. The distribution of the raft marker protein
ﬂotillin-2 (BD Biosciences; 1:2000) and non-raft marker protein
LAMP-2 (BD Pharmingen; 1:2000) was used as positive and negative
controls, respectively.
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